|
|
|
Name
|
Rib-X Pharmaceuticals |
|
Address:
|
300 George St.
|
|
City:
|
New Haven
|
|
State:
|
CT
|
|
Zip:
|
06511
|
|
Phone
|
203-624-5606
|
|
Web
Site:
|
www.rib-x.com
|
|
Fax:
|
624-5627
|
|
No. Employees
|
48
|
|
No. Researchers
|
40
|
|
Capitalization
|
WND
|
|
R&D Spending
|
WND
|
|
Major Investors
|
Warburg Pincus, Oxford Bioscience, S.R. One, Euclid SR. Partners,ABS Ventures, Axiom, Cardinal Partners, CI, Zerostage
|
|
Strategic Alliances
|
Yale University
|
|
Products
|
Anti-infective agents
|
|
CFO
|
Robert Conerly
|
|
Chief Scientific Research Officer
|
Graham Johnson
|
|
Ownership
|
Private
|
|
CEO
|
Susan Froshauer
|
|
Year Founded
|
2000
|
|
President
|
Susan Froshauer
|
|
|
|
|
|
|
|
Human Resource Manager/Director
|
Barbara Dodd
|
|
|
